Are you Dr. Ryerson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
# M1087
San Francisco, CA 94143Fax+1 415-476-5712
Summary
- Dr. Christopher Ryerson, MD is a pulmonologist in San Francisco, California.
Clinical Trials
- The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Start of enrollment: 2010 Feb 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- 34 citationsPrevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.Greta M Joy, Omri A Arbiv, Carmen K Wong, Stacey D Lok, Nicola A Adderley
European Respiratory Review. 2023-03-31 - 2235 citationsDiagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Ganesh Raghu, Martine Remy-Jardin, Jeffrey L. Myers, Luca Richeldi, Christopher J. Ryerson
American Journal of Respiratory and Critical Care Medicine. 2018-08-31 - 2542 citationsAn Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstiti...William D. Travis, Ulrich Costabel, David M Hansell, Talmadge E. King, David A. Lynch
American Journal of Respiratory and Critical Care Medicine. 2013-09-15
Press Mentions
Low BMI, Weight Loss Predict Mortality Risk in ILDJanuary 4th, 2022
What the Health?! Can Feather Duvets Really Cause Lung Disease?November 29th, 2019
Transbronchial Lung Cryobiopsy a Valid Diagnostic Option in Interstitial Lung DiseaseOctober 7th, 2019- Join now to see all
